Literature DB >> 27280064

A Narrative Review of Pharmacologic and Non-pharmacologic Interventions for Disorders of Consciousness Following Brain Injury in the Pediatric Population.

Nathan K Evanson1, Andrea L Paulson1, Brad G Kurowski1.   

Abstract

Traumatic brain injury (TBI) is the most common cause of long-term disability in the United States. A significant proportion of children who experience a TBI will have moderate or severe injuries, which includes a period of decreased responsiveness. Both pharmacological and non-pharmacological modalities are used for treating disorders of consciousness after TBI in children. However, the evidence supporting the use of potential therapies is relatively scant, even in adults, and overall, there is a paucity of study in pediatrics. The goal of this review is to describe the state of the science for use of pharmacologic and non-pharmacologic interventions for disorders of consciousness in the pediatric population.

Entities:  

Keywords:  Brain injury; Disorders of consciousness; Non-pharmacologic; Pediatrics; Pharmacologic; Traumatic brain injury

Year:  2016        PMID: 27280064      PMCID: PMC4894746          DOI: 10.1007/s40141-016-0108-7

Source DB:  PubMed          Journal:  Curr Phys Med Rehabil Rep        ISSN: 2167-4833


  67 in total

1.  INTRACELLULAR ACTIVITIES AND EVOKED POTENTIAL CHANGES DURING POLARIZATION OF MOTOR CORTEX.

Authors:  D P PURPURA; J G MCMURTRY
Journal:  J Neurophysiol       Date:  1965-01       Impact factor: 2.714

2.  Influence of transcortical d-c currents on cortical neuronal activity.

Authors:  O D CREUTZFELDT; G H FROMM; H KAPP
Journal:  Exp Neurol       Date:  1962-06       Impact factor: 5.330

3.  [Electrophysiological development under thalamic stimulation of post-traumatic persistent vegetative states. Apropos of 25 cases].

Authors:  P Deliac; E Richer; J Berthomieu; J Paty; F Cohadon; C Bensch
Journal:  Neurochirurgie       Date:  1993       Impact factor: 1.553

Review 4.  Transcranial magnetic stimulation: a possible treatment for TBI.

Authors:  Theresa Louise-Bender Pape; Joshua Rosenow; Gwyn Lewis
Journal:  J Head Trauma Rehabil       Date:  2006 Sep-Oct       Impact factor: 2.710

5.  Amantadine in pediatric patients with traumatic brain injury: a retrospective, case-controlled study.

Authors:  Liza B Green; Joseph E Hornyak; Edward A Hurvitz
Journal:  Am J Phys Med Rehabil       Date:  2004-12       Impact factor: 2.159

6.  Electrical treatment of coma via the median nerve.

Authors:  E B Cooper; J B Cooper
Journal:  Acta Neurochir Suppl       Date:  2003

7.  Comparison of indices of traumatic brain injury severity as predictors of neurobehavioral outcome in children.

Authors:  C M McDonald; K M Jaffe; G C Fay; N L Polissar; K M Martin; S Liao; J B Rivara
Journal:  Arch Phys Med Rehabil       Date:  1994-03       Impact factor: 3.966

8.  Cell therapy of comatose states.

Authors:  V I Seledtsov; S S Rabinovich; O V Parlyuk; O V Poveshchenko; S V Astrakov; D M Samarin; G V Seledtsova; V V Senyukov; V Ya Taraban; V A Kozlov
Journal:  Bull Exp Biol Med       Date:  2006-07       Impact factor: 0.804

9.  Morris water maze function and histologic characterization of two age-at-injury experimental models of controlled cortical impact in the immature rat.

Authors:  P David Adelson; Wendy Fellows-Mayle; Patrick M Kochanek; C Edward Dixon
Journal:  Childs Nerv Syst       Date:  2012-10-23       Impact factor: 1.475

10.  Long-lasting effects of human mesenchymal stem cell systemic administration on pain-like behaviors, cellular, and biomolecular modifications in neuropathic mice.

Authors:  Dario Siniscalco; Catia Giordano; Umberto Galderisi; Livio Luongo; Vito de Novellis; Francesco Rossi; Sabatino Maione
Journal:  Front Integr Neurosci       Date:  2011-12-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.